By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

Reject
United Kingdom | EnglishEN

Current country and language: United KingdomUnited Kingdom | English (EN)

ChinaChina
GermanyGermany
IrelandIreland
ItalyItaly
SpainSpain
United KingdomUnited Kingdom

YOU ARE LEAVING THE CURRENT LANGUAGE


Breathing life into medicines

Acquisitions

We are actively seeking opportunities to acquire individual products, portfolios of products or corporates and have established a strong contact network within the industry to facilitate this.

Over the past 16 years, we have completed a total of 34 acquisitions, acquiring products from several of the multi-national and mid-tier pharma companies, as well as making a number of corporate acquisitions.

We also welcome speculative approaches and are open to considering acquisitions in any therapy area or geography, although we are particularly interested in products which complement any of our existing therapy areas or which have sales originating in the ‘EU5’ territories (UK, France, Germany, Spain & Italy), the US or in China. Furthermore, with over 90 distributors worldwide, we are well placed to be able to handle further territories if required.
 

Our evaluation processes are well developed and managed by a dedicated team of professionals who engage with colleagues in both the commercial and functional support areas (technical operations, medical, regulatory, finance, legal) as required in order to facilitate a rapid and thorough assessment. As part of this process, the team routinely manage integration planning and any transitional arrangements, so as to make the subsequent transition as smooth as possible.

If you have an opportunity you’d like to discuss with us, please get in touch: bd@alliancepharmaceuticals.com or call our switchboard on +44 (0) 1249 466966.
 

Cronologia transazioni

giugno 2018

Nizoral

dicembre 2017

Vamousse

dicembre 2017

Ametop Gel 4% w/w

dicembre 2015

Sinclair Healthcare Products

febbraio 2015

MacuVision

Ulteriori informazioni